![Frontiers | Striatal Gαolf/cAMP Signal-Dependent Mechanism to Generate Levodopa-Induced Dyskinesia in Parkinson's Disease | Cellular Neuroscience Frontiers | Striatal Gαolf/cAMP Signal-Dependent Mechanism to Generate Levodopa-Induced Dyskinesia in Parkinson's Disease | Cellular Neuroscience](https://www.frontiersin.org/files/Articles/307889/fncel-11-00364-HTML/image_m/fncel-11-00364-g003.jpg)
Frontiers | Striatal Gαolf/cAMP Signal-Dependent Mechanism to Generate Levodopa-Induced Dyskinesia in Parkinson's Disease | Cellular Neuroscience
![Relating mode of action to clinical practice: Dopaminergic agents in Parkinson's disease - ScienceDirect Relating mode of action to clinical practice: Dopaminergic agents in Parkinson's disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1353802007001150-gr1.jpg)
Relating mode of action to clinical practice: Dopaminergic agents in Parkinson's disease - ScienceDirect
![Expert Perspectives – Parkinson's Disease Pathophysiology and Management | [current-page:pager]touchNEUROLOGY Expert Perspectives – Parkinson's Disease Pathophysiology and Management | [current-page:pager]touchNEUROLOGY](https://www.touchneurology.com/wp-content/uploads/sites/3/2018/06/figure3-pharmacological-systems.png)
Expert Perspectives – Parkinson's Disease Pathophysiology and Management | [current-page:pager]touchNEUROLOGY
![Safinamide as Add-on Therapy – Moving Beyond Dopamine for a Multifaceted Approach in Parkinson's Disease - touchNEUROLOGY Safinamide as Add-on Therapy – Moving Beyond Dopamine for a Multifaceted Approach in Parkinson's Disease - touchNEUROLOGY](https://www.touchneurology.com/wp-content/uploads/sites/3/2017/10/Figure_1_Dopaminergic_action_of_safinamide.png)
Safinamide as Add-on Therapy – Moving Beyond Dopamine for a Multifaceted Approach in Parkinson's Disease - touchNEUROLOGY
![Mechanism of action of Mucuna pruriens Levodopa (LD) to treat Parkinson... | Download Scientific Diagram Mechanism of action of Mucuna pruriens Levodopa (LD) to treat Parkinson... | Download Scientific Diagram](https://www.researchgate.net/profile/Anisha-Salim/publication/349590278/figure/fig2/AS:995051786227719@1614250241962/Mechanism-of-action-of-Mucuna-pruriens-Levodopa-LD-to-treat-Parkinson-disease-PD-A_Q640.jpg)
Mechanism of action of Mucuna pruriens Levodopa (LD) to treat Parkinson... | Download Scientific Diagram
![Elucidating the Mechanism of Action and Potential Interactions of MAO-B Inhibitors - Neurologic Clinics Elucidating the Mechanism of Action and Potential Interactions of MAO-B Inhibitors - Neurologic Clinics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f99e5923-5041-4a89-8f2a-34b390288b52/gr1_lrg.jpg)
Elucidating the Mechanism of Action and Potential Interactions of MAO-B Inhibitors - Neurologic Clinics
![Drugs Used in Parkinsonism and Other Movement Disorders - Katzung & Trevor's Pharmacology Examination and Board Review, 9th Edition Drugs Used in Parkinsonism and Other Movement Disorders - Katzung & Trevor's Pharmacology Examination and Board Review, 9th Edition](https://doctorlib.info/pharmacology/pharmacology-examination-board-review/pharmacology-examination-board-review.files/image154.jpg)
Drugs Used in Parkinsonism and Other Movement Disorders - Katzung & Trevor's Pharmacology Examination and Board Review, 9th Edition
![Dystonia and levodopa-induced dyskinesias in Parkinson's disease: Is there a connection? - ScienceDirect Dystonia and levodopa-induced dyskinesias in Parkinson's disease: Is there a connection? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0969996119302475-gr1.jpg)
Dystonia and levodopa-induced dyskinesias in Parkinson's disease: Is there a connection? - ScienceDirect
![Safinamide – A Unique Treatment Targeting Both Dopaminergic and Non-Dopaminergic Systems - touchNEUROLOGY Safinamide – A Unique Treatment Targeting Both Dopaminergic and Non-Dopaminergic Systems - touchNEUROLOGY](https://www.touchneurology.com/wp-content/uploads/sites/3/2016/11/Figure_2_Dual_mechanism_of_action_of_safinamide.png)
Safinamide – A Unique Treatment Targeting Both Dopaminergic and Non-Dopaminergic Systems - touchNEUROLOGY
![Levodopa - Pharmacokinetics, Mechanism of Action, Adverse Effects, Uses, Dose, Interactions | Antiparkinsonian Drugs | Pharmacology Levodopa - Pharmacokinetics, Mechanism of Action, Adverse Effects, Uses, Dose, Interactions | Antiparkinsonian Drugs | Pharmacology](http://www.pharmacy180.com/media/imgph02/btLr7av.jpg)